Clinical Trial to Evaluate the Efficacy and Safety of JP-1366 in Patients With Gastric Ulcer

NCT05448001 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

329

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric Ulcer

Interventions

DRUG: JP-1366 20mg
DRUG: Lansoprazole 30mg

Sponsor

Onconic Therapeutics Inc.